Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Women's Treatment Preferences for Moderate to Severe Vasomotor Symptoms (VMS) (WARMER Study)

NCT05300568 is registered in ClinicalTrials.gov with Astellas Pharma Europe Ltd. as lead sponsor.

NCT NCT05300568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05300568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Women's Treatment Preferences for Moderate to Severe Vasomotor Symptoms (VMS) (WARMER Study)
Lead sponsor
Astellas Pharma Europe Ltd.
Phase
Observational
Overall status
Completed
Start date
August 17, 2022
Completion date
August 27, 2023
Enrollment
1,465 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe vasomotor symptoms